Pharmaceuticals, Biotechnology and Life Sciences
BioAegis Therapeutics Highlights 2021 Accomplishments and 2022 OutlookNORTH BRUNSWICK, N.J., Jan. 24, 2022 (GLOBE NEWSWIRE) — BioAegis Therapeutics Inc., a…
Oslo (Norway), 24 January 2022 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announced that the company…
2021 TURNOVER EXCEPTIONAL LEVEL OF €184.1 MILLION • Continued growth in non-COVID activities (+14%)• Share of proprietary products increasing to…
NEW YORK, Jan. 24, 2022 (GLOBE NEWSWIRE) — Tiziana Life Sciences Ltd. (Nasdaq: TLSA) announced that its Board of Directors…
Two papers in The Lancet highlight one-year results from Roche’s phase III trials evaluating faricimab in neovascular or “wet” age-related…
Study further supports the expansion of clinical trials of MYCO-001 for the treatment of PTSD among the Veteran populationDENVER, Jan.…
CHENGDU, China, Jan. 21, 2022 (GLOBE NEWSWIRE) — Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global clinical-stage biotechnology company developing…
Phase 2 trial to evaluate reduction in heavy drinking as measured by a change in the World Health Organization drinking…
SANTA MONICA, Calif., Jan. 20, 2022 (GLOBE NEWSWIRE) — Correction: Opiant Pharmaceuticals, Inc. (“Opiant” or “Company”) (NASDAQ: OPNT), a specialty…
Robust financial strength positions Company to deploy Impact CapitalANN ARBOR, Mich., Jan. 20, 2022 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories,…